|
2007 Journal Article An assessment of the role of endoplasmic reticulum (ER) stress in the pathogenesis of HCVMcPhersonS, PowellEE, BarrieHD, CloustonAD and Jonsson, JR (2007). An assessment of the role of endoplasmic reticulum (ER) stress in the pathogenesis of HCV. Hepatology, 46 (4), 444A-444A. |
|
2007 Journal Article Progressive fibrosis in nonalcoholic steato hepatitis: Association with altered regeneration and a ductular reactionRichardson M. M., Jonsson, J. R., Powell, E. E., Brunt, EM, Neuschwander-Tetri, BA, Bhathal, PS, Dixon, JB, Weltman, MD, Tilg, H, Moschen, AR, Purdie, DM, Demetris, AJ and Clouston, A. D. (2007). Progressive fibrosis in nonalcoholic steato hepatitis: Association with altered regeneration and a ductular reaction. Gastroenterology, 133 (1), 80-90. doi: 10.1053/j.gastro.2007.05.012 |
|
2006 Journal Article Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1Walsh, MJ, Jonsson, JR, Richardson, MM, Lipka, GM, Purdie, DM, Clouston, D and Powell, EE (2006). Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1. Gut, 55 (4), 529-535. doi: 10.1136/gut.2005.069674 |
|
2006 Journal Article Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: A meta-analysis of individual patient dataLeandro, G, Mangia, A, Hui, J, Fabris, P, Rubbia-Brandt, L, Colloredo, G, Adinolfi, LE, Asselah, T, Jonsson, JR, Smedile, A, Terrault, N, Pazienza, V, Giordani, MT, Giostra, E, Sonzogni, A, Ruggiero, G, Marcellin, P, Powell, EE, George, J and Negro, F (2006). Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: A meta-analysis of individual patient data. Gastroenterology, 130 (6), 1636-1642. doi: 10.1053/j.gastro.2006.03.014 |
|
2005 Journal Article Steatosis is a cofactor in liver injury in hemochromatosisPowell, Elizabeth E., Ali, Azmat, Clouston, Andrew D., Dixon, Jeannette L., Lincoln, Douglas J., Purdie, David M., Fletcher, Linda M., Powell, Lawrie W. and Jonsson, Julie R. (2005). Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology, 129 (6), 1937-1943. doi: 10.1053/j.gastro.2005.09.015 |
|
2005 Journal Article Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosisClouston, Andrew D., Powell, Elizabeth E., Walsh, Meagan J., Richardson, Michelle M., Demetris, A. Jake and Jonsson, Julie R. (2005). Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis. Hepatology, 41 (4), 809-818. doi: 10.1002/hep.20650 |
|
2005 Journal Article Dangerous liaisons: The metabolic syndrome and nonalcoholic fatty liver diseasePowell, EE, Jonsson, JR and Clouston, AD (2005). Dangerous liaisons: The metabolic syndrome and nonalcoholic fatty liver disease. Annals of Internal Medicine, 143 (10), 753-754. doi: 10.7326/0003-4819-143-10-200511150-00015 |
|
2005 Journal Article Adiponectin and its receptors in patients with chronic hepatitis CJonsson, JR, Moschen, AR, Hickman, IJ, Richardson, MM, Kaser, S, Clouston, AD, Powell, EE and Tilg, H (2005). Adiponectin and its receptors in patients with chronic hepatitis C. Journal of Hepatology, 43 (6), 929-936. doi: 10.1016/j.jhep.2005.05.030 |
|
2005 Journal Article A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis CRichardson, M. M., Powell, E. E., Barrie, H. D., Clouston, A. D., Purdie, D. M. and Jonsson, J. R. (2005). A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C. Journal of Medical Genetics, 42 (7), 1-6. doi: 10.1136/jmg.2005.032557 |
|
2005 Journal Article Steatosis: Co-factor in other liver diseasesPowell, EE, Jonsson, JR and Clouston, AD (2005). Steatosis: Co-factor in other liver diseases. Hepatology, 42 (1), 5-13. doi: 10.1002/hep.20750 |
|
2004 Journal Article Nonalcoholic fatty liver disease: is all the fat bad?Clouston, A. D. and Powell, E. E. (2004). Nonalcoholic fatty liver disease: is all the fat bad?. Internal Medicine Journal, 34 (4), 187-191. doi: 10.1111/j.1444-0903.2004.00574.x |
|
2004 Journal Article Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejectionJonsson, Julie R., Gu, Wenyi, Vanags, Daina M., Bishop, G. Alex, McCaughan, Geoffrey W., Fawcett, Jonathon, Lynch, Stephen V., Balderson, Glenda A., Powell, Elizabeth E. and Clouston, Andrew D. (2004). Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejection. Liver Transplantation, 10 (3), 397-403. doi: 10.1002/lt.20084 |
|
2004 Journal Article Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional studyBuntain, HM, Greer, RM, Schluter, PJ, Wong, JCH, Batch, JA, Potter, JM, Lewindon, PJ, Powell, E, Wainwright, CE and Bell, SC (2004). Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax, 59 (2), 149-155. doi: 10.1136/thorax.2003.006726 |
|
2004 Journal Article Virus-specific CD8+ T lymphocytes within the normal human liverWard, S. M., Jonsson, J. R., Sierro, S., Clouston, A. D., Lucas, M., Vargas, A. L., Powell, E. E. and Klenerman, P. (2004). Virus-specific CD8+ T lymphocytes within the normal human liver. European Journal of Immunology, 34 (6), 1526-1531. doi: 10.1002/eji.200324275 |
|
2004 Journal Article Association between apolipoprotein E epsilon 4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis CGochee, Peter A., Powell, Elizabeth E., Purdie, David M., Pandeya, Nirmala, Kelemen, Livia, Shorthouse, Claudia, Jonsson, Julie R. and Kelly, Brian (2004). Association between apolipoprotein E epsilon 4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis C. Psychosomatics, 45 (1), 49-57. doi: 10.1176/appi.psy.45.1.49 |
|
2004 Journal Article Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of lifeHickman, IJ, Jonsson, JR, Prins, JB, Ash, S, Purdie, DM, Clouston, AD and Powell, EE (2004). Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut, 53 (3), 413-419. doi: 10.1136/gut.2003.027581 |
|
2004 Journal Article Steatosis and liver cell apoptosis in chronic hepatitis C: A mechanism for increased liver injuryWalsh, MJ, Vanags, DM, Clouston, AD, Richardson, MM, Purdie, DM, Jonsson, JR and Powell, EE (2004). Steatosis and liver cell apoptosis in chronic hepatitis C: A mechanism for increased liver injury. Hepatology, 39 (5), 1230-1238. doi: 10.1002/hep.20179 |
|
2004 Journal Article CCR5-Delta 32 mutation is strongly associated with primary sclerosing cholangitisEri, R, Jonsson, JR, Pandeya, N, Purdie, DM, Clouston, AD, Martin, N, Duffy, D, Powell, EE, Fawcett, J, Florin, THJ and Radford-Smith, GL (2004). CCR5-Delta 32 mutation is strongly associated with primary sclerosing cholangitis. Genes And Immunity, 5 (6), 444-450. doi: 10.1038/sj.gene.6364113 |
|
2004 Journal Article Chronic hepatitis C and steatosisClouston, A. D., Jonsson, J. R. and Powell, E. (2004). Chronic hepatitis C and steatosis. Current Hepatitis Reports, 3 (4), 123-128. |
|
2003 Journal Article In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapyHickman, I. J., Powell, E. E., Prins, J. B., Clouston, A. D., Ash, S., Purdie, D. M. and Jonsson, J. R. (2003). In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. Journal of Hepatology, 39 (6), 1042-1048. doi: 10.1016/S0168-8278(03)00463-X |
